Valuation: Labcorp Holdings Inc.

Market Cap 30.08B 27.26B 25.21B 22.75B 42.87B 2,836B 44.38B 303B 120B 1,515B 113B 110B 4,810B P/E 2026 *
27.3x
P/E 2027 * 24.6x
Enterprise Value 35.25B 31.94B 29.55B 26.66B 50.24B 3,324B 52.01B 355B 141B 1,776B 132B 129B 5,636B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.22x
Free-Float
99.65%
Yield 2026 *
0.79%
Yield 2027 * 0.79%
1 day-0.49%
1 week+1.07%
Current month+2.52%
1 month+16.75%
3 months+16.46%
6 months+45.85%
Current year+47.67%
1 week 363.19
Extreme 363.19
375.1
1 month 314.68
Extreme 314.685
375.1
Current year 245
Extreme 245
375.1
1 year 245
Extreme 245
375.1
3 years 191.97
Extreme 191.97
375.1
5 years 191.97
Extreme 191.97
375.1
10 years 98.02
Extreme 98.02
375.1
Date Insider Type Main position Quantity % Market Cap. Importance
3/11/26 Sell

EVP and President, Diagnostics

-306 0.0004%
2/11/26 Tax

EVP and President, Diagnostics

-194 0.0002%
2/11/26 Tax

Chief Technology Officer

-118 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%+1.07%+38.81%+78.08% 30.08B
-0.49%+6.56%+14.83%+30.44% 114B
-0.32%+0.82%+5.59%+110.06% 104B
-1.19%+2.71%+56.20%+512.22% 46.27B
+0.62%+2.17%+10.06%+99.55% 33.33B
-0.02%+1.55%+38.86%+94.05% 28.56B
-0.29%+0.95%+48.27%+389.27% 22.76B
-0.70%-1.35%-17.21%-19.66% 19.92B
+1.15%+2.99%-4.11%+34.18% 17.15B
-0.34%+6.05%+122.53% - 14.84B
Average -0.21%+2.39%+31.38%+147.58% 43B
Weighted average by Cap. -0.34%+2.90%+23.16%+134.56%

Financials

2026 *2027 *
Net sales 14.83B 13.44B 12.43B 11.21B 21.13B 1,398B 21.88B 149B 59.2B 747B 55.64B 54.46B 2,371B 15.63B 14.16B 13.1B 11.82B 22.27B 1,473B 23.05B 157B 62.38B 787B 58.64B 57.39B 2,498B
Net income 1.11B 1.01B 932M 841M 1.58B 105B 1.64B 11.19B 4.44B 55.98B 4.17B 4.08B 178B 1.22B 1.1B 1.02B 921M 1.74B 115B 1.8B 12.26B 4.86B 61.33B 4.57B 4.47B 195B
Net Debt 5.17B 4.68B 4.33B 3.91B 7.37B 487B 7.63B 52.04B 20.64B 260B 19.4B 18.98B 826B 4.59B 4.16B 3.85B 3.47B 6.55B 433B 6.78B 46.26B 18.34B 231B 17.24B 16.88B 735B
Projected Income Statement - Annual - Labcorp Holdings Inc.
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
13/11/26 US$370.48 -0.49% 488,973
12/11/26 US$372.32 +0.02% 519,331
11/11/26 US$372.23 +0.36% 741,770
10/11/26 US$370.88 -0.26% 510,426
09/11/26 US$371.83 +1.43% 797,777
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Labcorp Holdings Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
370.48USD
Average target price
390.06USD
Spread / Average Target
+5.29%